Generate Biomedicines’ $400M IPO Puts AI Drug Discovery Back in Focus / OncoDaily
oncodaily - Generate Biomedicines priced its U.S. initial public offering on February 26, 2026, selling 25 million shares at $16 each for gross proceeds of $400 million, with trading expected on the Nasdaq under […]
#healthcare #pharmaceuticals #biotech #drugdevelopment #digitalhealth #healthcarefinance
Friday, February 27, 2026, 11:22 pm / permalink 19912 / 6 stories in 11 days
UHS posts 11.5% operating margin in 2025 as net income jumps 30% / Beckers
Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services recorded a net income of $1.5 billion in 2025, up from $1.1 billion in 2024, according to its Feb. 25 financial report. Eight things to know: 1. The for-profit system reported an operating income of $2 …
#healthcare #publichealth #governmentpolicy #behavioralhealth #hospitaloperations #healthcarefinance
Friday, February 27, 2026, 11:25 am / permalink 19887 / 10 stories in 11 days
Cancer blood test fails to catch disease earlier in major study / Medical Express
medicalxpress - A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.
#healthcare #publichealth #governmentpolicy #biotech #medicaldevices #oncology
Thursday, February 26, 2026, 7:24 pm / permalink 19851 / 7 stories in 12 days
Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial / Endpoints
Elizabeth Cairns / endpoints - Novo Nordisk’s GLP-1/amylin combo drug CagriSema was not as good as Eli Lilly’s marketed obesity shot Zepbound in a head-to-head study, the Danish company said Monday. Patients in the REDEFINE 4 ...
#obesity #healthcare #pharmaceuticals #elililly #novonordisk #weightloss #drugdevelopment
Thursday, February 26, 2026, 7:23 am / permalink 19788 / 12 stories in 13 days
More Research, Less Cancer: £250m raised to transform the future of cancer research / Cancer Research UK
Charlotte Mathé / cancerresearchuk - We’ve reached an incredible moment - £250m raised for our More Research, Less Cancer campaign. This milestone brings us more than halfway to our £400m goal and accelerates our mission to prevent, detect and treat cancer earlier and more effectively. The p…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #oncology
Tuesday, February 24, 2026, 1:24 pm / permalink 19675 / 53 stories in 14 days
FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases 2026 / OncoDaily
oncodaily - The U.S. Food and Drug Administration (FDA) has released groundbreaking draft guidance introducing a new regulatory framework designed to accelerate the development and approval of individualized therapies for patients with […]
#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda
Tuesday, February 24, 2026, 12:25 pm / permalink 19669 / 6 stories in 14 days
ChatGPT Health performance in a structured test of triage recommendations / Nature
Ashwin Ramaswamy / nature - Nature Medicine, Published online: 23 February 2026; doi:10.1038/s41591-026-04297-7A stress test of ChatGPT Health triage revealed missed high-risk emergencies and inconsistent activation of suicide-crisis safeguards, raising safety concerns for consumer-…
#healthcare #publichealth #governmentpolicy #fda #digitalhealth #medicaldevices
Tuesday, February 24, 2026, 11:25 am / permalink 19660 / 18 stories in 14 days
Gilead to acquire cell therapy manufacturer for $7.8B / Beckers
Paige Twenter / beckershospitalreview - In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive…
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #fda #oncology
Monday, February 23, 2026, 4:23 pm / permalink 19605 / 7 stories in 15 days
Justice Department sues OhioHealth over alleged anticompetitive insurer contracts / Healthcare Dive
Sydney Halleman / healthcaredive - The DOJ filed a lawsuit last week accusing OhioHealth of leveraging its market power to force insurers to include its providers in their networks.
Monday, February 23, 2026, 2:23 pm / permalink 19594 / 7 stories in 15 days
Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves EFS, OS and pCR in Patients with MIBC Who Are Ineligible for Cisplatin / ESMO
esmo - Findings from the KEYNOTE-905/EV-303 study
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology
Monday, February 23, 2026, 2:22 am / permalink 19558 / 15 stories in 16 days
Data and Decisions in Advanced NSCLC at the 2026 TTLC Symposia – IASLC / OncoDaily
oncodaily - International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn: “2026 TTLC Symposia Event Data and Decisions in Advanced NSCLC The treatment landscape for advanced NSCLC is evolving […]
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology
Monday, February 23, 2026, 2:22 am / permalink 19557 / 23 stories in 16 days
Brain injury is almost ten times more common in unhoused people. Addressing it is key to reducing homelessness / Medical Express
medicalxpress - On any given night, 60,000 people in Canada will go to sleep homeless. Research estimates that more than half of them have had a brain injury at one point in their lives, most of them being injured before becoming homeless. An estimated 22.5% live with mo…
#healthcare #publichealth #governmentpolicy
Saturday, February 21, 2026, 6:23 pm / permalink 19543 / 4 stories in 17 days
‘You’re not the Lone Ranger’ anymore: Medical education evolves for team-based care / Beckers
Paige Twenter / beckershospitalreview - As U.S. healthcare increasingly adopts team-based care, medical schools are working to prepare students for future care delivery models, according to a Feb. 18 article from the Association of American Medical Colleges. Team-based care, or a coordinated ba…
#healthcare #publichealth #fda #digitalhealth #medicaldevices
Saturday, February 21, 2026, 12:22 pm / permalink 19529 / 3 stories in 17 days
Optum unveils Value Connect, its AI-powered tool to support value-based care / Fierce
fiercehealthcare - Optum is rolling out a new AI tool that aims to address some of the key barriers to value-based care, from data fragmentation to administrative burden.
Saturday, February 21, 2026, 10:22 am / permalink 19522 / 21 stories in 18 days
A novel C. diff vaccine shows promise / Beckers
Mariah Taylor / beckershospitalreview - Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary toxins, according to a Feb. 18 system news release. Th…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #vaccinesafety
Saturday, February 21, 2026, 7:21 am / permalink 19520 / 2 stories in 18 days
Novartis signs macrocyclic deal with Unnatural Products for $100M upfront / Endpoints
Kyle LaHucik / endpoints - Novartis will pay $100 million upfront to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines. The move allows the Swiss pharma giant to delve ...
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment
Saturday, February 21, 2026, 6:22 am / permalink 19517 / 2 stories in 18 days
Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA / MedCity
Frank Vinluan / medcitynews - The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. Analysts say it’s a surprising delay considering bitopertin is one of the first drugs in a new FD…
#healthcare #pharmaceuticals #biotech #drugdevelopment #fda
Saturday, February 21, 2026, 6:22 am / permalink 19516 / 5 stories in 18 days
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks / Nature
Kellen K. Petersen / nature - Nature Medicine, Published online: 19 February 2026; doi:10.1038/s41591-026-04206-yPlasma p-tau217 tests used to develop clocks that predict when cognitively unimpaired individuals would develop symptoms of Alzheimerʼs disease.
#healthcare #publichealth #biotech #drugdevelopment #fda #medicaldevices
Saturday, February 21, 2026, 2:22 am / permalink 19513 / 13 stories in 18 days
Hims to buy Australia’s Eucalyptus for $240M upfront in global push / Endpoints
Ngai Yeung / endpoints - In a bid to build out its global presence, Hims is buying Australian digital health company Eucalyptus in a deal worth $240 million upfront. The deal announced Thursday morning would allow Hims to launch in ...
#healthcare #mergersandacquisitions #corporatetakeover #digitalhealth
Saturday, February 21, 2026, 1:23 am / permalink 19510 / 5 stories in 18 days
CDC confirms 910 measles cases in 2026; South Carolina remains hardest hit / Beckers
Paige Twenter / beckershospitalreview - Six weeks into 2026, the CDC has confirmed 910 measles cases. If the pace of transmission continues, this year could far outpace the 2,280 cases detected across the U.S. in 2025, as 2026’s total is already 40% of 2025’s. The hardest-hit state is South Car…
#healthcare #publichealth #cdc #vaccinesafety
Saturday, February 21, 2026, 1:22 am / permalink 19508 / 11 stories in 18 days